Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M605492200 on October 26, 2006

J. Biol. Chem., Vol. 281, Issue 52, 39839-39851, December 29, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/52/39839    most recent
M605492200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Perria, C. L.
Right arrow Articles by Raghavan, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perria, C. L.
Right arrow Articles by Raghavan, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Catalytic Site Modifications of TAP1 and TAP2 and Their Functional Consequences*

Christopher L. Perria1, Vijayalakshmi Rajamanickam1, Philip E. Lapinski, and Malini Raghavan2

From the Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan 48109-0620

The transporter associated with antigen processing (TAP), a member of the ATP binding cassette (ABC) family of transmembrane transporters, transports peptides across the endoplasmic reticulum membrane for assembly of major histocompatibility complex class I molecules. Two subunits, TAP1 and TAP2, are required for peptide transport, and ATP hydrolysis by TAP1·TAP2 complexes is important for transport activity. Two nucleotide binding sites are present in TAP1·TAP2 complexes. Compared with other ABC transporters, the first nucleotide binding site contains non-consensus catalytic site residues, including Asp668 in the Walker B region of TAP1 (in place of a highly conserved glutamic acid), and Gln701 in the switch region of TAP1 (in place of a highly conserved histidine). At the second nucleotide binding site, a glutamic acid (TAP2 Glu632) follows the Walker B motif, and the switch region contains a histidine (TAP2 His661). We found that alterations at Glu632 and His661 of TAP2 significantly reduced peptide translocation and/or TAP-induced major histocompatibility complex class I surface expression. Alterations of TAP1 Asp668 alone or in combination with TAP1 Gln701 had only small effects on TAP activity. Thus, the naturally occurring Asp668 and Gln701 alterations of TAP1 are likely to contribute to attenuated catalytic activity at the first nucleotide binding site (the TAP1 site) of TAP complexes. Due to its enhanced catalytic activity, the second nucleotide binding site (the TAP2 site) appears to be the main site driving peptide transport. A mechanistic model involving one main active site is likely to apply to other ABC transporters that have an asymmetric distribution of catalytic site residues within the two nucleotide binding sites.


Received for publication, June 8, 2006 , and in revised form, October 3, 2006.

Note Added in Proof—Findings relevant to this study have recently been published (46).

* This work was supported by National Institutes of Health Grant AI-44115 (to M. R.) and by an Investigator Award from the Cancer Research Institute (to M. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Both authors contributed equally to this work.

2 To whom correspondence should be addressed: 5641 Medical Science Bldg. II, University of Michigan Medical School, Ann Arbor, MI 48109-0620. Tel.: 734-647-7752; Fax: 734-764-3562; E-mail: malinir{at}umich.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
FASEB J.Home page
E. Procko, M. L. O'Mara, W. F. D. Bennett, D. P. Tieleman, and R. Gaudet
The mechanism of ABC transporters: general lessons from structural and functional studies of an antigenic peptide transporter
FASEB J, May 1, 2009; 23(5): 1287 - 1302.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement